Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain

NCT06487065 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06487065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06487065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 17, 2024
Completion date
October 25, 2024
Enrollment
33 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma